Improving Physical Function in Older Adults Using an Anti-inflammation Drug: The RIGHT Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Clazakizumab
Related studies linked through entity extraction aliases.
Clazakizumab vs. Placebo - COVID-19 Infection
- Status
- UNKNOWN
- Phase
- PHASE2
Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection
- Status
- TERMINATED
- Phase
- PHASE2
Clazakizumab (Anti-Interleukin 6 (IL-6) Monoclonal) Compared to Placebo for Coronavirus Disease 2019 (COVID-19)
- Status
- COMPLETED
- Phase
- PHASE2
PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study
- Status
- COMPLETED
- Phase
- PHASE2
Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients
- Status
- TERMINATED
- Phase
- PHASE3
Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2